A policy model to evaluate the benefits, risks and costs of warfarin pharmacogenomic testing.
Meckley LM; Gudgeon JM; Anderson JL; Williams MS; Veenstra DL; Pharmacoeconomics, 2010, vol. 28, issue 1, p 61, ISSN 11792027. ISBN 11792027.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef